CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs
Off-target editing remains a concern for therapeutic applications of CRISPR-Cas9. Here the authors present CRISPR GUARD, which uses very short non-cleaving gRNAs to prevent editing at off-target sites.
Guardado en:
Autores principales: | Matthew A. Coelho, Etienne De Braekeleer, Mike Firth, Michal Bista, Sebastian Lukasiak, Maria Emanuela Cuomo, Benjamin J. M. Taylor |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5ca3e3c9d50c40859d3cc5b4b7665184 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural roles of guide RNAs in the nuclease activity of Cas9 endonuclease
por: Youngbin Lim, et al.
Publicado: (2016) -
Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease
por: Matthew J. Johnson, et al.
Publicado: (2018) -
Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein
por: April Pawluk, et al.
Publicado: (2017) -
Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs
por: John C. Rose, et al.
Publicado: (2020) -
Tag-seq: a convenient and scalable method for genome-wide specificity assessment of CRISPR/Cas nucleases
por: Hongxin Huang, et al.
Publicado: (2021)